SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: RJMC who wrote (3740)11/28/2000 9:03:14 AM
From: TI2, TechInvestorToo  Read Replies (1) | Respond to of 5665
 
Bob,
So what timeline would you guess for fast track? What conferences?
TIA
TI2



To: RJMC who wrote (3740)11/29/2000 10:27:41 PM
From: Gary Mohilner  Respond to of 5665
 
Bob, and all,

Check out the news, we just signed a new Partnership with Genzyme Transgenic, they will produce the MAB for N901-DM1 for future use. I think this is a strong endorsement of a drug that hasn't yet made it into the clinic.

By the way Aahem, on R.B. attended Mitch's presentation in France, I'd suggest checking out his posts today.

Talk to you later,

Gary


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News